Investissement Quebec
Records under this name other than patents Investissement Quebec holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,572,536 | Contact Assessment of Balloon Catheters Formerly held Lapsed on the fee record Ended Feb 21, 2025 · Medium confidence | Lapsed on the fee record | Ended Feb 21, 2025 | Medium confidence |
| US 8,900,222 | Method and Apparatus for Inflating and Deflating Balloon Catheters Formerly held Term ended Term ended Mar 23, 2024 · Medium confidence | Term ended | Term ended Mar 23, 2024 | Medium confidence |
| US 9,808,301 | Method and Apparatus for Inflating and Deflating Balloon Catheters Formerly held Term ended Term ended Mar 23, 2024 · Medium confidence | Term ended | Term ended Mar 23, 2024 | Medium confidence |
| US 6,358,687 | Methods for monitoring the binding of A1/UP1 to single-stranded nucleic acid sequences, and to measure the effect of this binding on telomere extension and protection Term ended Term ended Mar 27, 2020 · USPTO record | Term ended | Term ended Mar 27, 2020 | USPTO record |
| US 6,746,445 | Cryoblation Catheter Handle Formerly held Lapsed on the fee record Ended Jun 8, 2016 · Low confidence | Lapsed on the fee record | Ended Jun 8, 2016 | Low confidence |
| US 6,294,332 | Composition and methods for modulating the length of telomeres Lapsed on the fee record Ended Sep 25, 2013 · USPTO record | Lapsed on the fee record | Ended Sep 25, 2013 | USPTO record |
| US 6,737,508 | DNA sequences from staphylococus aureus bacteriophages 3A, 77, and 96 that encode anti-microbial polypeptides Lapsed on the fee record Ended May 18, 2012 · USPTO record | Lapsed on the fee record | Ended May 18, 2012 | USPTO record |
| US 7,326,541 | Fragments and Variants of Staphylococcus Aureus Dnag Primase, and Uses Thereof Lapsed on the fee record Ended Feb 5, 2012 · High confidence | Lapsed on the fee record | Ended Feb 5, 2012 | High confidence |
| US 7,101,969 | Compositions and methods involving an essential Staphylococcus aureus gene and its encoded protein Lapsed on the fee record Ended Sep 5, 2010 · USPTO record | Lapsed on the fee record | Ended Sep 5, 2010 | USPTO record |
| US 6,376,652 | Compositions and methods involving an essential Staphylococcus aureus gene and its encoded protein Lapsed on the fee record Ended Apr 23, 2010 · USPTO record | Lapsed on the fee record | Ended Apr 23, 2010 | USPTO record |